Key partnership to accelerate adoption of image management and AI digital pathology workflows
Learn more about the PathPresenter and Paige collaboration at an exclusive preconference workshop on November 3 at Pathology Visions 2024 conference
28 Oct 2024PathPresenter, a comprehensive enterprise pathology workflow platform known for its secure, scalable, multi-tenant infrastructure, is partnering with Paige, the leader in next-generation AI technology for healthcare. Together, the two companies aim to revolutionize digital pathology workflows in hospitals and laboratories worldwide by integrating Paige’s advanced Diagnostic AI applications directly into PathPresenter’s platform.
The collaboration between will offer a unified solution for customers, simplifying AI adoption in pathology and setting new standards in digital pathology management. This integration promises to enhance efficiency and empower pathologists with tools for more precise diagnoses and streamlined workflows.
The companies will unveil their partnership at Pathology Visions 2024 conference, Orlando, Florida. On November 3, at 1:30pm ET, Paige will join PathPresenter for an exclusive preconference workshop, where they will showcase the breakthrough solution developed for Memorial Sloan Kettering Cancer Center (MSKCC).
"We're thrilled to integrate Paige's state-of-the-art AI models into PathPresenter’s IMS, elevating the sign-out process while also advancing our educational and research applications. Paige’s innovation – marked by the first-ever FDA approval of a pathology AI application – combined with their exciting Generative AI capabilities, truly has the potential to transform pathology as we know it," said Dr. Rajendra Singh, founder of PathPresenter.
"We are excited to partner with PathPresenter to bring Paige’s best-in-class Diagnostic AI applications to a broader network of hospitals and labs,” said Peter Hamilton, General Manager of Diagnostics of Paige. “Through this collaboration, we’re advancing our mission to bring our AI to many more cancer patients through partnership, open solutions and industry consolidation.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>